Micafungin Labatec 50 mg

Micafungin Labatec 50 mg is a medicine authorised by Swissmedic under authorisation number 69511. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 June 2024 and the authorisation is limited until 17 June 2029. ATC code J02AX05 places the medicine in the group Antimycotics for systemic use.

  • Dispensing category A
  • Authorisation number 69511
  • ATC J02AX05
  • Synthetic medicines
Authorisation data
Authorisation number69511
NameMicafungin Labatec 50 mg
Full nameMicafungin Labatec 50 mg, poudre pour solution à diluer pour perfusion
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ02AX05
First authorisation18 June 2024
Authorisation validity17 June 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Micafungin Labatec 50 mg, poudre pour solution à diluer pour perfusionA18 June 2024
2Micafungin Labatec 100 mg, poudre pour solution à diluer pour perfusionA18 June 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J02AX0508.06.0.A
21Durchstechflasche(n)J02AX0508.06.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Micafungin Labatec 50 mg authorised in Switzerland?

Yes. Micafungin Labatec 50 mg is authorised by Swissmedic under authorisation number 69511, data as of 01 September 2026. The authorisation is limited until 17 June 2029.

Which dispensing category does Micafungin Labatec 50 mg have?

Micafungin Labatec 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Micafungin Labatec 50 mg?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com